Exane Derivatives’s AT&T T Stock Holding History

Exane Derivatives’s Portfolio T Stock Details T Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,324	Closed	-$256K	–	673
2016 Q4	$256K	Hold	1,324	–	–	0.05%	192
2016 Q3	$145K	Buy	+1,324	New	+$41.8K	0.02%	217
2016 Q2	–	Sell	-2,979	Closed	-$805K	–	624
2016 Q1	$805K	Sell	2,979 -2,052	-41%	-$56.8K	0.11%	104
2015 Q4	$167K	Buy	5,031 +662	+15%	+$16.8K	0.02%	171
2015 Q3	$34.2K	Hold	4,369	–	–	﹤0.01%	295
2015 Q2	$217K	Hold	4,369	–	–	0.02%	207
2015 Q1	$96.2K	Buy	4,369 +1,324	+43%	+$33.7K	0.01%	270
2014 Q4	$115K	Buy	+3,045	New	+$79K	0.02%	272

Other funds holding T

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Exane Derivatives's T Position: Q2 2022 in Review

Exane Derivatives reduced its AT&T (T) stake by 96% in Q2 2022, selling an estimated $757K and leaving 1,440 shares worth $30.2K. The position accounts for 0.02% of the portfolio, ranked #344.

Exane Derivatives first reported a position in T in Q4 2015 and has held it in 23 quarters since. The position peaked at $13.1M in Q4 2015. 2,396 funds tracked by Wall St. Rank hold T as of Q2 2022.

Exane Derivatives held 1,440 shares of AT&T worth $30.2K as of Q2 2022.
Exane Derivatives sold 37,978 AT&T shares in Q2 2022, an estimated $757K.
AT&T made up 0.02% of Exane Derivatives's portfolio in Q2 2022, its #344 holding.
Exane Derivatives first reported a position in AT&T in Q4 2015 and has held it in 23 quarters since.
Exane Derivatives's AT&T position peaked at $13.1M in Q4 2015.
2,396 funds tracked by Wall St. Rank held AT&T as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.